Real-World Weight Loss Outcomes by Obesity Management Approaches in Japan: Descriptive Findings from the J-ORBIT Database Linked to Electronic Medical Records (J-ORBIT2)
Obesity-associated burden in terms of ORHDs was common among Japanese IwOD. Although IwOD tended to have the highest weight reduction after bariatric surgery, this treatment is indicated for a highly restrictive population and requires specific criteria to be met, leaving many IwOD with unmet needs. These IwOD may need pharmacotherapy for better weight management than that provided by current options.
Authors
- Seiji Nishikage (ORCID: https://orcid.org/0009-0007-4348-6118)
- Satoshi Osaga (ORCID: https://orcid.org/0000-0003-4459-2469)
- YUSHI HIROTA
- Takuto Kojima
- Tomotaka Shingaki (ORCID: https://orcid.org/0000-0003-1568-9763)
- Masamichi Ishii (ORCID: https://orcid.org/0000-0002-4228-1723)
- Ambrish Singh
- Kengo Miyo
- Wataru Ogawa
Institutions
- Eli Lilly (Japan) (JP)
- Eli Lilly (India) (IN)
- Institute for Health Economics and Policy (JP)
- Kobe University (JP)
Publication Details
- Journal
- Diabetes Therapy
- Published
- 2026-01-19
- DOI
- https://doi.org/10.1007/s13300-025-01837-1
- Primary Topic
- Bariatric Surgery and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Eli Lilly and Company
- Mitsubishi Tanabe Pharma Corporation
- Eli Lilly Japan